vs
Side-by-side financial comparison of Hologic (HOLX) and MODINE MANUFACTURING CO (MOD). Click either name above to swap in a different company.
Hologic is the larger business by last-quarter revenue ($1.0B vs $805.0M, roughly 1.3× MODINE MANUFACTURING CO). Hologic runs the higher net margin — 17.1% vs -5.9%, a 23.0% gap on every dollar of revenue. On growth, MODINE MANUFACTURING CO posted the faster year-over-year revenue change (30.5% vs 2.5%). Hologic produced more free cash flow last quarter ($215.2M vs $-17.1M). Over the past eight quarters, MODINE MANUFACTURING CO's revenue compounded faster (15.5% CAGR vs 1.5%).
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
Modine Manufacturing is a thermal management company established in 1916 in the United States. The company started as Modine Manufacturing Company by Arthur B Modine who patented the Spirex radiator for tractors. The Modine company manufactured the Turbotube radiator for Ford Model T cars. The company built the world's first vehicular wind tunnel in Racine, Wisconsin in 1941. During WWII, Modine manufactured aftercoolers for the P-51 Mustang fighter plane. After WWII, Modine introduced the Ai...
HOLX vs MOD — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $805.0M |
| Net Profit | $179.1M | $-47.4M |
| Gross Margin | 56.0% | 23.1% |
| Operating Margin | 22.6% | 11.1% |
| Net Margin | 17.1% | -5.9% |
| Revenue YoY | 2.5% | 30.5% |
| Net Profit YoY | -10.9% | -215.6% |
| EPS (diluted) | $0.79 | $-0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $805.0M | ||
| Q3 25 | $1.0B | $738.9M | ||
| Q2 25 | $1.0B | $682.8M | ||
| Q1 25 | $1.0B | $647.2M | ||
| Q4 24 | $1.0B | $616.8M | ||
| Q3 24 | $988.0M | $658.0M | ||
| Q2 24 | $1.0B | $661.5M | ||
| Q1 24 | $1.0B | $603.5M |
| Q4 25 | $179.1M | $-47.4M | ||
| Q3 25 | $187.2M | $44.4M | ||
| Q2 25 | $194.9M | $51.2M | ||
| Q1 25 | $-17.4M | $49.6M | ||
| Q4 24 | $201.0M | $41.0M | ||
| Q3 24 | $178.6M | $46.1M | ||
| Q2 24 | $194.5M | $47.3M | ||
| Q1 24 | $169.9M | $25.8M |
| Q4 25 | 56.0% | 23.1% | ||
| Q3 25 | 55.6% | 22.3% | ||
| Q2 25 | 56.3% | 24.2% | ||
| Q1 25 | 37.5% | 25.6% | ||
| Q4 24 | 56.8% | 24.3% | ||
| Q3 24 | 56.4% | 25.2% | ||
| Q2 24 | 55.4% | 24.6% | ||
| Q1 24 | 53.3% | 22.4% |
| Q4 25 | 22.6% | 11.1% | ||
| Q3 25 | 22.6% | 9.9% | ||
| Q2 25 | 24.9% | 11.1% | ||
| Q1 25 | -0.7% | 11.5% | ||
| Q4 24 | 22.5% | 9.6% | ||
| Q3 24 | 23.3% | 11.4% | ||
| Q2 24 | 24.1% | 11.2% | ||
| Q1 24 | 20.7% | 7.8% |
| Q4 25 | 17.1% | -5.9% | ||
| Q3 25 | 17.8% | 6.0% | ||
| Q2 25 | 19.0% | 7.5% | ||
| Q1 25 | -1.7% | 7.7% | ||
| Q4 24 | 19.7% | 6.6% | ||
| Q3 24 | 18.1% | 7.0% | ||
| Q2 24 | 19.2% | 7.2% | ||
| Q1 24 | 16.7% | 4.3% |
| Q4 25 | $0.79 | $-0.90 | ||
| Q3 25 | $0.84 | $0.83 | ||
| Q2 25 | $0.86 | $0.95 | ||
| Q1 25 | $-0.08 | $0.92 | ||
| Q4 24 | $0.87 | $0.76 | ||
| Q3 24 | $0.75 | $0.86 | ||
| Q2 24 | $0.82 | $0.88 | ||
| Q1 24 | $0.72 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.4B | $98.7M |
| Total DebtLower is stronger | $2.5B | $570.7M |
| Stockholders' EquityBook value | $5.2B | $1.1B |
| Total Assets | $9.2B | $2.5B |
| Debt / EquityLower = less leverage | 0.48× | 0.51× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.4B | $98.7M | ||
| Q3 25 | $2.2B | $83.8M | ||
| Q2 25 | $1.9B | $124.5M | ||
| Q1 25 | $1.6B | $71.6M | ||
| Q4 24 | $2.0B | $83.8M | ||
| Q3 24 | $2.3B | $78.6M | ||
| Q2 24 | $2.4B | $72.9M | ||
| Q1 24 | $2.2B | $60.1M |
| Q4 25 | $2.5B | $570.7M | ||
| Q3 25 | $2.5B | $525.8M | ||
| Q2 25 | $2.5B | $482.1M | ||
| Q1 25 | $2.5B | $296.7M | ||
| Q4 24 | $2.5B | $330.0M | ||
| Q3 24 | $2.5B | $359.1M | ||
| Q2 24 | $2.5B | $405.7M | ||
| Q1 24 | $2.6B | $399.9M |
| Q4 25 | $5.2B | $1.1B | ||
| Q3 25 | $5.0B | $1.1B | ||
| Q2 25 | $4.8B | $1.0B | ||
| Q1 25 | $4.6B | $910.2M | ||
| Q4 24 | $4.8B | $855.1M | ||
| Q3 24 | $5.1B | $858.8M | ||
| Q2 24 | $5.0B | $788.4M | ||
| Q1 24 | $4.8B | $747.6M |
| Q4 25 | $9.2B | $2.5B | ||
| Q3 25 | $9.0B | $2.4B | ||
| Q2 25 | $8.8B | $2.2B | ||
| Q1 25 | $8.5B | $1.9B | ||
| Q4 24 | $8.7B | $1.8B | ||
| Q3 24 | $9.2B | $1.9B | ||
| Q2 24 | $8.9B | $1.9B | ||
| Q1 24 | $8.7B | $1.9B |
| Q4 25 | 0.48× | 0.51× | ||
| Q3 25 | 0.50× | 0.50× | ||
| Q2 25 | 0.52× | 0.48× | ||
| Q1 25 | 0.55× | 0.33× | ||
| Q4 24 | 0.53× | 0.39× | ||
| Q3 24 | 0.49× | 0.42× | ||
| Q2 24 | 0.51× | 0.51× | ||
| Q1 24 | 0.53× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $229.9M | $24.7M |
| Free Cash FlowOCF − Capex | $215.2M | $-17.1M |
| FCF MarginFCF / Revenue | 20.5% | -2.1% |
| Capex IntensityCapex / Revenue | 1.4% | 5.2% |
| Cash ConversionOCF / Net Profit | 1.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.0B | $-20.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $229.9M | $24.7M | ||
| Q3 25 | $355.1M | $1.4M | ||
| Q2 25 | $343.3M | $27.7M | ||
| Q1 25 | $169.4M | $54.8M | ||
| Q4 24 | $189.3M | $60.7M | ||
| Q3 24 | $367.0M | $57.3M | ||
| Q2 24 | $405.8M | $40.5M | ||
| Q1 24 | $292.4M | $39.6M |
| Q4 25 | $215.2M | $-17.1M | ||
| Q3 25 | $341.4M | $-30.5M | ||
| Q2 25 | $330.5M | $200.0K | ||
| Q1 25 | $153.9M | $27.1M | ||
| Q4 24 | $172.5M | $44.7M | ||
| Q3 24 | $350.6M | $43.8M | ||
| Q2 24 | $385.3M | $13.7M | ||
| Q1 24 | $279.6M | $-4.3M |
| Q4 25 | 20.5% | -2.1% | ||
| Q3 25 | 32.5% | -4.1% | ||
| Q2 25 | 32.3% | 0.0% | ||
| Q1 25 | 15.3% | 4.2% | ||
| Q4 24 | 16.9% | 7.2% | ||
| Q3 24 | 35.5% | 6.7% | ||
| Q2 24 | 38.1% | 2.1% | ||
| Q1 24 | 27.5% | -0.7% |
| Q4 25 | 1.4% | 5.2% | ||
| Q3 25 | 1.3% | 4.3% | ||
| Q2 25 | 1.3% | 4.0% | ||
| Q1 25 | 1.5% | 4.3% | ||
| Q4 24 | 1.6% | 2.6% | ||
| Q3 24 | 1.7% | 2.1% | ||
| Q2 24 | 2.0% | 4.1% | ||
| Q1 24 | 1.3% | 7.3% |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 1.90× | 0.03× | ||
| Q2 25 | 1.76× | 0.54× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | 0.94× | 1.48× | ||
| Q3 24 | 2.05× | 1.24× | ||
| Q2 24 | 2.09× | 0.86× | ||
| Q1 24 | 1.72× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
MOD
| Data Centers | $296.9M | 37% |
| Performance Technologies | $266.0M | 33% |
| Hvac Technologies | $107.1M | 13% |
| Air Cooled | $92.4M | 11% |
| Lb White | $25.6M | 3% |
| Climate By Design | $10.2M | 1% |
| Absolutaire | $7.0M | 1% |
